Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma

New effective therapies are greatly needed for metastatic uveal melanoma, which has a very poor prognosis with a median survival of less than 1 y. The melanocortin 1 receptor (MC1R) is expressed in 94% of uveal melanoma metastases, and a MC1R-specific ligand (MC1RL) with high affinity and selectivit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nucl Med
Autors principals: Tafreshi, Narges K., Tichacek, Christopher J., Pandya, Darpan N., Doligalski, Michael L., Budzevich, Mikalai M., Kil, HyunJoo, Bhatt, Nikunj B., Kock, Nancy D., Messina, Jane L., Ruiz, Epifanio E., Delva, Nella C., Weaver, Adam, Gibbons, William R., Boulware, David C., Khushalani, Nikhil I., El-Haddad, Ghassan, Triozzi, Pierre L., Moros, Eduardo G., McLaughlin, Mark L., Wadas, Thaddeus J., Morse, David L.
Format: Artigo
Idioma:Inglês
Publicat: Society of Nuclear Medicine 2019
Matèries:
Theranostics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681690/
https://ncbi.nlm.nih.gov/pubmed/30733316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.217240
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars